From Medical News Today A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment. In their report published online in the Journal of the National Cancer Institute, Massachusetts General Hospital (MGH) Cancer Center investigators describe finding …
CHMP recommends EU approval of Roche’s Subcutaneous Herceptin for HER2 positive breast cancer
(Menafn – M2 PRESSWIRE via COMTEX) New injectable administration takes two to five minutes, rather than 30 to 90 minutes with the current intravenous form, potentially saving both healthcare resources and patients’ time Herceptin is a personalised medicine used to treat more than 80,000 HER2-positive breast cancer patients in Europe each year Roche (six:RO)(six:ROG)(otcqx:RHHBY) is pleased to announce that the …
Independence Day Through the Eyes of a Breast Cancer Survivor
The 4th of July has always been a huge celebration in our country to commemorate our independence from England so many centuries ago. There are parades and cook outs and fireworks galore. Many people travel at this time because the kids are out of school and the holiday allows for an extra vacation day. But I can’t help but wonder …
“Miracle” Breast Cancer Drug and “Youth Hormone” Pill Steal Show at Prestigious Endocrine Society Conference
PRNewswire/ — It may seem like an odd pairing: an oral growth hormone-boosting supplement and possible cure for breast cancer. But these were two of the most talked about topics at ENDO 2013, The Endocrine Society’s 95th Annual Meeting & Expo that just convened in San Francisco. And now some are saying this focus by some of the top internal medicine …
Breakthrough in breast cancer surgery without disfigurement
Serious tissue damage and disfigurement are a major fallout of most cancer therapies, but the one for breast cancer in particular has life-altering impact on women. Chicago-based Ananda Chakrabarty, a world-renowned pioneering biotech scientist, and Washington-based Susan Finston, a veteran of the biotech industry, together believe they are potentially close to resolving this major medical challenge. Finston passionately talks about …
MD Anderson Researcher Reassesses Avastin’s Function In Treating Brain Cancer
From BioNews TX With the cancer drug Avastin on the ropes after losing FDA support for the treatment of breast cancer two years ago and an increasing chorus of criticism, an MD Anderson researcher has weighed in on where he thinks the drug’s effectiveness lies. In a recent cancer study conducted at MD Anderson for the initial treatment of glioblastoma, one …
Moderate Alcohol Consumption And Breast Cancer Risk Association
From A Greenearth A comprehensive study has evaluated the association of moderate alcohol consumption throughout adult life and breast cancer risk. The researchers use prospectively obtained data from the 105,986 women participating in the Nurses’ Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 follow ups. The International Scientific Forum of Alcohol Research …
A nano ray of hope for breast cancer patients
Amy Fernandes IIT-B prof finds way to reduce drugs toxicity. Hollywood actor Angelina Jolie’s recent double mastectomy may have intensified the debate on breast cancer, but the number of women affected by it only continues to rise. One of the many causes of fatality is the high toxicity of the treatment and the current disability of affected cells to absorb …
Doctor/patient communication: Who’s doing the talking?
by ANDREW M. SEAMAN NEW YORK (Reuters Health) – There’s room – and need – for improvement in the discussions between doctor and patient that go into medical decision-making, according to research out on Monday. In four studies and a commentary published in JAMA Internal Medicine, the authors look at various aspects of doctors’ dialogue with patients about prognoses, options …
New urine-based test to detect breast cancer
From Zee News Washington: Scientists have developed a new urine-based screening method to diagnose breast cancer and determine its severity even before it can be detected with a mammogram. A Missouri University of Science and Technology researcher used a device called a P-scan, to detect the concentration of certain metabolites called pteredines in urine samples. These biomarkers are present in …